
Join to view full profile
3601 The Vanderbilt ClinicNashville, TN 37232
Phone+1 615-322-3000
Dr. Fedorov is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Residency, Internal Medicine, 2017 - 2020
State University of New York Downstate Medical Center College of MedicineClass of 2017
Certifications & Licensure
TN State Medical License 2023 - 2028
KY State Medical License 2025 - 2027
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- FLAG-Ida-venetoclax in acute myeloid leukemia: real-world efficacy and the impact of venetoclax duration on outcomes.Kateryna Fedorov, Melanie Naranjo, Jayda Esplund, Sara Leidy, Sarah E Profitt
Leukemia & Lymphoma. 2026-07-15 - NCCN Guidelines® Insights: Acute Myeloid Leukemia, Version 3.2026.Daniel A Pollyea, Jessica K Altman, Rita Assi, Kimo Bachiashvili, Vijaya Raj Bhatt
Journal of the National Comprehensive Cancer Network. 2026-06-01 - Selinexor and Venetoclax Combination in Patients With Relapsed or Refractory Acute Myeloid Leukemia.Somedeb Ball, Farrukh T Awan, Ben K Tomlinson, Tess Stopczynski, Melissa A Fischer
American Journal of Hematology. 2026-05-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









